Denosumab biosimilar by Lupin for Post Menopausal Osteoporosis: Likelihood of Approval

Denosumab biosimilar is under clinical development by Lupin and currently in Phase III for Post Menopausal Osteoporosis.

AstraZeneca rolls up cardiovascular, renal and metabolic interconnections in film and digital effort

AstraZeneca is putting its cardiovascular, renal and metabolic (CVRM) portfolio in the spotlight with a short film and digital campaign. The two-minute video lays out

September 19, 2023

Sen. Durbin’s Surgery; Dangerous Bacteria on Apple Watches? Princess Anne Discharged

Note that some links may require registration or subscription. Sen. Dick Durban (D-Ill.) underwent hip replacement surgery and is recovering in his home state. (AP)

June 29, 2024

Biologics emerge as dominating molecule type in solid tumour indication – Pharmaceutical Technology

Biologics offer great utility in solid tumours compared to traditional small molecules. Credit: SciePro via Shutterstock. Traditionally, the pharmaceutical landscape has been dominated by small

October 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.